TriMas Corporation $TRS Stock Position Decreased by PNC Financial Services Group Inc.

PNC Financial Services Group Inc. cut its stake in shares of TriMas Corporation (NASDAQ:TRSFree Report) by 26.0% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 5,211 shares of the industrial products company’s stock after selling 1,834 shares during the period. PNC Financial Services Group Inc.’s holdings in TriMas were worth $122,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of TRS. Deutsche Bank AG boosted its position in shares of TriMas by 45.6% in the fourth quarter. Deutsche Bank AG now owns 36,305 shares of the industrial products company’s stock worth $893,000 after buying an additional 11,363 shares during the period. GAMMA Investing LLC boosted its position in shares of TriMas by 3,802.9% in the first quarter. GAMMA Investing LLC now owns 14,948 shares of the industrial products company’s stock worth $350,000 after buying an additional 14,565 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of TriMas by 3.7% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 23,106 shares of the industrial products company’s stock worth $568,000 after buying an additional 834 shares during the period. Envestnet Asset Management Inc. boosted its position in shares of TriMas by 44.5% in the first quarter. Envestnet Asset Management Inc. now owns 22,765 shares of the industrial products company’s stock worth $533,000 after buying an additional 7,016 shares during the period. Finally, Barclays PLC boosted its position in shares of TriMas by 51.4% in the fourth quarter. Barclays PLC now owns 104,163 shares of the industrial products company’s stock worth $2,560,000 after buying an additional 35,371 shares during the period. 99.42% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at TriMas

In other news, Director Shawn Sedaghat bought 72,937 shares of the company’s stock in a transaction dated Thursday, May 22nd. The shares were bought at an average cost of $26.16 per share, with a total value of $1,908,031.92. Following the acquisition, the director owned 1,883,758 shares in the company, valued at $49,279,109.28. This trade represents a 4.03% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Adrianne Shapira purchased 4,000 shares of the stock in a transaction on Thursday, June 5th. The stock was bought at an average cost of $25.82 per share, for a total transaction of $103,280.00. Following the completion of the acquisition, the director owned 8,476 shares in the company, valued at approximately $218,850.32. This trade represents a 89.37% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders bought 78,203 shares of company stock worth $2,045,220. 14.20% of the stock is owned by insiders.

Analyst Ratings Changes

TRS has been the subject of several recent analyst reports. Wall Street Zen raised TriMas from a “hold” rating to a “buy” rating in a research report on Sunday, June 1st. KeyCorp set a $45.00 price objective on TriMas and gave the stock an “overweight” rating in a report on Tuesday, August 12th. Finally, BWS Financial reiterated a “buy” rating and set a $45.00 price objective (up from $40.00) on shares of TriMas in a report on Wednesday, July 30th. Two investment analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average price target of $45.00.

Get Our Latest Stock Report on TriMas

TriMas Stock Performance

TRS stock opened at $37.19 on Wednesday. The company has a debt-to-equity ratio of 0.59, a current ratio of 2.59 and a quick ratio of 1.44. The company has a 50 day moving average price of $31.29 and a 200 day moving average price of $26.24. TriMas Corporation has a fifty-two week low of $19.33 and a fifty-two week high of $37.49. The stock has a market capitalization of $1.51 billion, a PE ratio of 40.87 and a beta of 0.66.

TriMas (NASDAQ:TRSGet Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The industrial products company reported $0.61 earnings per share for the quarter, topping the consensus estimate of $0.50 by $0.11. The firm had revenue of $274.76 million during the quarter, compared to analysts’ expectations of $251.18 million. TriMas had a net margin of 3.83% and a return on equity of 11.49%. TriMas’s revenue was up 14.2% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.43 EPS. TriMas has set its FY 2025 guidance at 1.950-2.100 EPS. Analysts forecast that TriMas Corporation will post 1.69 EPS for the current year.

TriMas Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, August 12th. Stockholders of record on Tuesday, August 5th were issued a $0.04 dividend. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date of this dividend was Tuesday, August 5th. TriMas’s dividend payout ratio is presently 17.58%.

TriMas Company Profile

(Free Report)

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.

Featured Articles

Want to see what other hedge funds are holding TRS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TriMas Corporation (NASDAQ:TRSFree Report).

Institutional Ownership by Quarter for TriMas (NASDAQ:TRS)

Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.